In increase to concerns of increased brown iris pigmentation with Latisse, many of the "experts" continually state that the risk are associated with Lumigan (the glaucoma application) because it is "much more potent". That is inaccurate and misleading. They both contain 0.3% of bimatoprost. So how is it more "potent"?? What percentage of glaucoma patients experience this side effect using Lumigan directly in the eye. I have heard as few as 3% and as many as 50%
Why Do Some Say Lumigan is More Potent Than Latisse?- Both Contain 3% Bimatoprost
Doctor Answers (3)
Lumigan = Latisse
Be aware, however, that long term use of Latisse has caused fat atrophy in a few patients. This is relatively new -- most practitioners aren't aware of the potential side effect.
Lumigan more potent than Latisse?
Question: Why Do Some Say Lumigan is More Potent than Latisse?
Answer: Latisse and Lumigan are the same product. The only difference is the type
of application and indication for appropriate usage. If you have specific
questions about potency, you should probably contact the manufacturer, Allergan,
but they will most likely give you the same answer.
Lumigan vs latisse
good question. Both medications are FDA approved for different indications and the studies on Latisse (small amount of 0.3% bimatoprost in a vehicle made for that purpose) are different than the studies on Lumigan (drop of 0.3% bimatoprost in a vehicle for eye distribution). One is not more potent than the other- the solution that the active ingredient is in and the amount to be applied is vastly different however- leading to increased concerns with side effects. The data on iris pigmentation is best obtained from the respective companies.